Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway

Simalikalactone E (SkE) is a quassinoid extracted from a widely used Amazonian antimalarial remedy. Although SkE has previously been shown to have cytostatic and/or cytotoxic activities in some tumor cell lines, its mechanism of action has not yet been characterized. We show here that SkE in the hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Robert, Guillaume, Jullian, Valérie, Jacquel, Arnaud, Ginet, Clémence, Dufies, Maeva, Torino, Stephanie, Pottier, Anaïs, Peyrade, Frederic, Tartare-Deckert, Sophie, Bourdy, Geneviève, Deharo, Eric, Auberger, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2012
Materias:
Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681504/
https://www.ncbi.nlm.nih.gov/pubmed/23518796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681504/
https://www.ncbi.nlm.nih.gov/pubmed/23518796

Ejemplares similares